NM_000535.7:c.1204C>T

Variant names:

• chr7-5987561-G-A
• rs587782789
• NM_000535.7:c.1204C>T

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1 PM2 PP5_Very_Strong

The NM_000535.7(PMS2):​c.1204C>T​(p.Gln402*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,084 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q402Q) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

• Frequency:
  • Genomes: not found (cov: 31)
  • Exomes 𝑓: 6.8e-7 (0 hom.)
• Consequence: PMS2 NM_000535.7 stop_gained
• Clinical Significance: Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4
• Conservation: PhyloP100: -0.957
• Publications: 0 publications found

Genes affected

PMS2 (HGNC:9122): (PMS1 homolog 2, mismatch repair system component) The protein encoded by this gene is a key component of the mismatch repair system that functions to correct DNA mismatches and small insertions and deletions that can occur during DNA replication and homologous recombination. This protein forms heterodimers with the gene product of the mutL homolog 1 (MLH1) gene to form the MutL-alpha heterodimer. The MutL-alpha heterodimer possesses an endonucleolytic activity that is activated following recognition of mismatches and insertion/deletion loops by the MutS-alpha and MutS-beta heterodimers, and is necessary for removal of the mismatched DNA. There is a DQHA(X)2E(X)4E motif found at the C-terminus of the protein encoded by this gene that forms part of the active site of the nuclease. Mutations in this gene have been associated with hereditary nonpolyposis colorectal cancer (HNPCC; also known as Lynch syndrome) and Turcot syndrome. [provided by RefSeq, Apr 2016]

PMS2 Gene-Disease associations (from GenCC):

• Lynch syndrome

  Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
• Lynch syndrome 4

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
• mismatch repair cancer syndrome 1

  Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
• mismatch repair cancer syndrome 4

  Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
• malignant pancreatic neoplasm

  Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
• ovarian cancer

  Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
• Muir-Torre syndrome

  Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
• rhabdomyosarcoma

  Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
• breast cancer

  Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
• prostate cancer

  Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
• hereditary breast carcinoma

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

ACMG classification

Our verdict: Pathogenic. The variant received 18 ACMG points.

• PVS1: Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 7-5987561-G-A is Pathogenic according to our data. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-5987561-G-A is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 1748379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
PMS2	NM_000535.7	c.1204C>T	p.Gln402*	stop_gained	Exon 11 of 15	ENST00000265849.12	NP_000526.2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
PMS2	ENST00000265849.12	c.1204C>T	p.Gln402*	stop_gained	Exon 11 of 15	1	NM_000535.7	ENSP00000265849.7

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome AF: 6.84e-7 AC: 1 AN: 1461084 Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0 AN XY: 726888

African (AFR) AF: 0.00 AC: 0 AN: 33454

American (AMR) AF: 0.00 AC: 0 AN: 44722

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 26132

East Asian (EAS) AF: 0.00 AC: 0 AN: 39694

South Asian (SAS) AF: 0.00 AC: 0 AN: 86238

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53344

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 5766

European-Non Finnish (NFE) AF: 9.00e-7 AC: 1 AN: 1111366

Other (OTH) AF: 0.00 AC: 0 AN: 60368

GnomAD4 genome Cov.: 31

ClinVar

Significance: Pathogenic/Likely pathogenic

Submissions summary: Pathogenic:4

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Lynch syndrome Pathogenic:1

Nov 23, 2021

Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.Gln402X variant in PMS2 has not been reported in individuals with PMS2-associated cancers or in large population studies. This nonsense variant leads to a premature termination codon at position 402, which is predicted to lead to a truncated or absent protein. Loss of function of the PMS2 gene is an established disease mechanism in autosomal dominant Lynch syndrome. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant Lynch syndrome. ACMG/AMP Criteria applied: PVS1, PM2_Supporting. -

Hereditary nonpolyposis colorectal neoplasms Pathogenic:1

Aug 19, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change creates a premature translational stop signal (p.Gln402*) in the PMS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PMS2 are known to be pathogenic (PMID: 21376568, 24362816). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1748379). For these reasons, this variant has been classified as Pathogenic. -

Hereditary cancer-predisposing syndrome Pathogenic:1

Feb 14, 2022

Ambry Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.Q402* pathogenic mutation (also known as c.1204C>T), located in coding exon 11 of the PMS2 gene, results from a C to T substitution at nucleotide position 1204. This changes the amino acid from a glutamine to a stop codon within coding exon 11. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -

Lynch syndrome 4 Pathogenic:1

Sep 20, 2023

Myriad Genetics, Inc.

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Uncertain	0.049	T
BayesDel_noAF	Benign	-0.17
CADD	Uncertain	25
DANN	Benign	0.97
Eigen	Benign	-0.45
Eigen_PC	Benign	-0.86
FATHMM_MKL	Benign	0.043	N
PhyloP100		-0.96
Vest4		0.69
GERP RS		-6.2
Mutation Taster		=4/196	disease causing (fs/PTC)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs587782789; hg19: chr7-6027192; COSMIC: COSV107226163;